Your browser doesn't support javascript.
loading
Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study.
Müller-Jensen, Leonie; Zierold, Sarah; Versluis, Judith M; Boehmerle, Wolfgang; Huehnchen, Petra; Endres, Matthias; Mohr, Raphael; Compter, Annette; Blank, Christian U; Hagenacker, Tim; Meier, Friedegund; Reinhardt, Lydia; Gesierich, Anja; Salzmann, Martin; Hassel, Jessica C; Ugurel, Selma; Zimmer, Lisa; Banks, Patricia; Spain, Lavinia; Soon, Jennifer A; Enokida, Tomohiro; Tahara, Makoto; Kähler, Katharina C; Seggewiss-Bernhardt, Ruth; Harvey, Catriona; Long, Georgina V; Schöberl, Florian; von Baumgarten, Louisa; Hundsberger, Thomas; Schlaak, Max; French, Lars E; Knauss, Samuel; Heinzerling, Lucie M.
Afiliação
  • Müller-Jensen L; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Department of Neurology with Experimental Neurology, Charitéplatz 1, 10117 Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innov
  • Zierold S; SERIO Side Effect Registry Immuno-Oncology, Germany; Department of Dermatology and Allergy, University Hospital, Ludwig-Maximilian Universität Munich, Frauenlobstr. 9-11, 80337 München, Germany.
  • Versluis JM; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Boehmerle W; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Department of Neurology with Experimental Neurology, Charitéplatz 1, 10117 Berlin, Germany.
  • Huehnchen P; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Department of Neurology with Experimental Neurology, Charitéplatz 1, 10117 Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innov
  • Endres M; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Department of Neurology with Experimental Neurology, Charitéplatz 1, 10117 Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innov
  • Mohr R; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Department of Hepatology & Gastroenterology, Augustenburger Platz 1, 13353 Berlin, Germany.
  • Compter A; Department of Neuro-Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Blank CU; Department of Medical Oncology, Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Hagenacker T; Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, Hufelandstr. 55, 45147 Essen, Germany.
  • Meier F; Skin Cancer Center at the University Cancer Center Dresden and National Center for Tumor Diseases, Dresden, Germany; Department of Dermatology, University Hospital Carl Gustav Carus, TU Dresden, Germany.
  • Reinhardt L; Skin Cancer Center at the University Cancer Center Dresden and National Center for Tumor Diseases, Dresden, Germany; Department of Dermatology, University Hospital Carl Gustav Carus, TU Dresden, Germany.
  • Gesierich A; Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.
  • Salzmann M; Skin Cancer Center, Department of Dermatology and National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.
  • Hassel JC; Skin Cancer Center, Department of Dermatology and National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.
  • Ugurel S; Department of Dermatology, Venerology und Allergology, University Hospital Essen, Essen, Germany.
  • Zimmer L; Department of Dermatology, Venerology und Allergology, University Hospital Essen, Essen, Germany.
  • Banks P; Andrew Love Cancer Centre, University Hospital Geelong, Geelong, Australia.
  • Spain L; Medical Oncology Department, Peter MacCallum Cancer Center, Melbourne, Australia.
  • Soon JA; Medical Oncology Department, Peter MacCallum Cancer Center, Melbourne, Australia.
  • Enokida T; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa 277-8577, Japan.
  • Tahara M; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa 277-8577, Japan.
  • Kähler KC; Department of Dermatology, Venerology and Allergology, University of Schleswig-Holstein Hospital, Campus Kiel, Germany.
  • Seggewiss-Bernhardt R; Department of Hematology and Oncology, Sozialstiftung Bamberg, Bamberg, Germany.
  • Harvey C; Melanoma Institute Australia, University of Sydney, Royal North Shore and Mater Hospitals, Sydney, Australia.
  • Long GV; Melanoma Institute Australia, University of Sydney, Royal North Shore and Mater Hospitals, Sydney, Australia.
  • Schöberl F; Department of Neurology, Ludwig-Maximilian Universität, Marchioninistraße 15, 83177 München, Germany.
  • von Baumgarten L; Department of Neurology, Ludwig-Maximilian Universität, Marchioninistraße 15, 83177 München, Germany; Division of Neuro-Oncology, Department of Neurosurgery, Ludwig-Maximilian Universität, Marchioninistraße 15, 83177 München, Germany.
  • Hundsberger T; Department of Neurology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • Schlaak M; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Department of Dermatology, Venerology and Allergology, Charitéplatz 1, 10117 Berlin, Germany.
  • French LE; Department of Dermatology and Allergy, University Hospital, Ludwig-Maximilian Universität Munich, Frauenlobstr. 9-11, 80337 München, Germany; Dr. Philip Frost, Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Knauss S; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Department of Neurology with Experimental Neurology, Charitéplatz 1, 10117 Berlin, Germany; SERIO Side Effect Registry Immuno-Oncology, Germany; Berlin Institute of Health at Chari
  • Heinzerling LM; SERIO Side Effect Registry Immuno-Oncology, Germany; Department of Dermatology and Allergy, University Hospital, Ludwig-Maximilian Universität Munich, Frauenlobstr. 9-11, 80337 München, Germany; Department of Dermatology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), University Hospital E
Eur J Cancer ; 175: 224-235, 2022 11.
Article em En | MEDLINE | ID: mdl-36155116
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Herpesvirus Humano 1 / Encefalite / Glioma Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Herpesvirus Humano 1 / Encefalite / Glioma Idioma: En Ano de publicação: 2022 Tipo de documento: Article